129 results
Page 3 of 7
8-K
EX-99.2
p5o pxb9h39srs
15 Apr 20
Securities Purchase Agreement
12:00am
8-K
EX-99.1
bqats
5 Mar 20
Securities Purchase Agreement
4:45pm
8-K
EX-5.1
afwy shj5
5 Mar 20
Securities Purchase Agreement
4:45pm
8-K
EX-99.2
453g54p
5 Mar 20
Securities Purchase Agreement
4:45pm
8-K
EX-99.3
206zxagpkobp qq
5 Mar 20
Securities Purchase Agreement
4:45pm
424B5
u2d5xpf2kqeoqwxtnv2
5 Mar 20
Prospectus supplement for primary offering
8:46am
8-K
EX-99.2
2ohlu3m4ixi
3 Mar 20
Securities Purchase Agreement
4:40pm
8-K
EX-5.1
mc6jcgjqdf09vwtd7tx2
3 Mar 20
Securities Purchase Agreement
4:40pm
8-K
EX-99.3
ez22yt
3 Mar 20
Securities Purchase Agreement
4:40pm
8-K
EX-99.1
h6wm5 5l2oy
3 Mar 20
Securities Purchase Agreement
4:40pm
424B5
dsjcrhbcjp2fzkep
2 Mar 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-4.2
1znfe2yzcid
9 Jan 20
Entry into a Material Definitive Agreement
8:40am
8-K
884jqpmypnmjti el0k
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am
8-K
EX-4.1
2snv034p sme
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am
8-K
EX-5.1
ub2n46ndoxx0 mqs
11 Dec 19
Biocept Announces Pricing of $10.0 Million Underwritten Public Offering
12:00am